The Joint Institute (JI) for Clinical and Translational Research is a long-running institutional partnership with Peking University Health Science Center, in Beijing. The JI has funded more than 75 collaborative research projects to date co-designed and co-led by investigators at both institutions. Three newly awarded projects for 2023 focus on various aspects of cancer research and are part of recent efforts by the JI to prioritize specific research areas for collaborations.
Joint Institute Seminar: Clarifying mechanisms of lineage plasticity in prostate and breast cancers
Professor of Internal Medicine Joshi Alumkal and his Peking University Health Science Center collaborator Hongquan Zhang will present their new Joint Institute project as part of seminar series on cancer-focused research collaborations with PKUHSC.